S. Mohan

Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial.

Zev A. Binder, J. Waterfall, J. Brogdon, 2024, Nature cancer.

Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approach

Zev A. Binder, S. Bakas, H. Akbari, 2024, Scientific reports.